Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Type 1 Diabetes Mellitus Clinical Trials

15 recruiting trials for Type 1 Diabetes Mellitus. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
15
Total Trials
15
Recruiting Now
0
Phase 3 Trials
10
Sponsors

Recruiting Trials

RECRUITINGNCT04096794

Chinese Alliance for Type 1 Diabetes Multi-center Collaborative Research

The China Alliance for Type 1 Diabetes (CAT1D) is committed to exploring and implementing the model of graded diagnosis and treatment of type 1 diabetes and comprehensive...

Sponsor: Second Xiangya Hospital of Central South UniversityEnrolling: 5001 location
RECRUITINGNCT06081231

Open-Source Artificial Pancreas System Use Among People With Type 1 Diabetes Mellitus in China

This real-world observational study aims to reveal the current status of the open-source artificial pancreas system (APS) use among people with T1DM in China and assess the...

Sponsor: Third Affiliated Hospital, Sun Yat-Sen UniversityEnrolling: 5001 location
RECRUITINGNCT07409701

Gamification Intervertion in Children With Type 1 Diabetes

Objective: This study aims to examine the effect of education provided through gamification methods on health literacy and quality of life in children diagnosed with type 1...

Sponsor: KTO Karatay UniversityEnrolling: 521 location
RECRUITINGEarly Phase 1NCT06609356

Cardiometabolic Benefit of Reducing Iatrogenic Hyperinsulinemia Using Insulin Adjunctive Therapy in Type 1 Diabetes

This study aims to understand the heart and blood sugar health benefits of using an adjunctive therapy to lower high insulin levels in people with type 1 diabetes. The...

Sponsor: Vanderbilt University Medical CenterEnrolling: 271 location
RECRUITINGPhase 4NCT03878459

Dapagliflozin Plus Pioglitazone in T1DM

Purpose: To examine the effect of addition of combination therapy with dapagliflozin plus pioglitazone to insulin on glucose control and plasma ketone concentration in patients...

Sponsor: The University of Texas Health Science Center at San AntonioEnrolling: 1203 locations
RECRUITINGPhase 4NCT03463564

Insulin Pump vs Multiple Daily Injections of Insulin and Glyco-metabolic Control in Type 1 Diabetic Patients

The transition from the Pediatric clinic to the adult care is a challenging period for young adults with type 1 diabetes, due to the high risk of poor glycemic control. Achieving...

Sponsor: University of Campania Luigi VanvitelliEnrolling: 1501 location
RECRUITINGNCT07434154

Evaluation of Oxidative Stress: Comparison Between Type 1 Diabetes Mellitus and Latent Autoimmune Diabetes in Adults

After obtaining informed consent, the investigators will recruit 75 patients with T1DM and 75 with LADA with an age ≥ 18 years and ≤ 75 years, of both sexes. All patients will be...

Sponsor: Fondazione IRCCS Policlinico San Matteo di PaviaEnrolling: 751 location
RECRUITINGPhase 1 / Phase 2NCT06575426

A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes...

This study is First In Human study for Encapsulated Porcine Islet Cells for Xenotransplantation (OPF-310). The purpose of this study to assess the safety, tolerability, and...

Sponsor: Otsuka Pharmaceutical Factory, Inc.Enrolling: 131 location
RECRUITINGNCT07145671

The COCCOS Study: a Transition Program for Young Persons With Chronic Conditions

A study is undertaken to examine the feasibility of the newly developed transition program in adolescents with type 1 diabetes, asthma and obesity in a multicentric setting....

Sponsor: Universiteit AntwerpenEnrolling: 1501 location
RECRUITINGNCT06390371

Implementing the Spotlight AQ Platform in Adolescent/ Young Adult (16-25 Years Old) Type 1 Diabetics (T1D)

The goal of this clinical trial is to compare the Spotlight AQ survey platform to the standard of care (SOC) pre-clinic assessment in adolescents \& young adults (16-25 years old)...

Sponsor: Children's Mercy Hospital Kansas CityEnrolling: 601 location
RECRUITINGPhase 1NCT06280703

A Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus (T1DM)

The main purpose of this study is to look at the amount of the study drug LY3938577 that gets into the blood stream and how long it takes the body to get rid of it. At a later...

Sponsor: Eli Lilly and CompanyEnrolling: 1181 location
RECRUITINGPhase 1 / Phase 2NCT06783309

CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes...

This study is a Phase 1b/2a First-in-Human (FIH) clinical trial to assess the safety, tolerability, pharmacodynamics (PD), and efficacy of multiple ascending doses of CNP-103. The...

Sponsor: COUR Pharmaceutical Development Company, Inc.Enrolling: 7220 locations
RECRUITINGNCT06709755

A Hybrid Effectiveness-implementation Trial to Reduce Diabetes Distress in Teenagers

The investigators will assess both effectiveness (primary) and implementation (secondary) outcomes for a distress-reducing intervention, Supporting Teen Problem Solving (STePS)....

Sponsor: Ann & Robert H Lurie Children's Hospital of ChicagoEnrolling: 3601 location
RECRUITINGNCT02306005

Insulin Therapy and Lipoproteins' Profile in Type 1 Diabetes.

The aim of the study is to evaluate the effect of insulin therapy in patients with newly diagnosed type 1 diabetes on quantitative and qualitative changes of plasma lipoproteins,...

Sponsor: Poznan University of Medical SciencesEnrolling: 3001 location
RECRUITINGNCT07461805

Characterization of Type 1 Diabetes Subgroup: An Artificial Intelligence Analysis of Clinical and Glucometric Features

The goal of this observational study is to characterize different subgroups among patients with type 1 diabetes. The main research question is: Are there distinct subtypes among...

Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauEnrolling: 8001 location